Teresa Lotodo gave a good introduction to this lecture by defining MM and other plasma dyscrasias. She dwelt on diagnosis, risk stratification, staging and monitoring of MM.
Of interest to me was her discourse on IHC and FISH. The use of CD markers to identify the clonality of the abnormal plasma cells.
She also discussed bone marrow aspiration, indications, possible sites, processing of tissues, preparation of slides and reading of the slides by pathologists.
There were pictures and charts to aid understanding of her lectures.
It was well delivered and I learnt a lot.
In depth coverage of the topic was done, with good organization and a variety of experts involved in the care of breast cancer patient. The course also had a good balance between local and worldwide data and practices.
Consider group discussion on real life patients amongst fellow course participants in future.